NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) will host a conference call at 9 a.m. (ET) on Tuesday, September 9 to review data presented at the 44th annual meeting of the European Association for the Study of Diabetes (EASD), being held from September 7-11 in Rome. Company executives will provide an overview of data presented at the meeting on the diabetes portfolio and address inquiries from investors and analysts.
